Log-In To See Your Dermatologist

Delivering follow-up care to acne patients through the Web (“eVisit”) produced the same clinical outcomes as office visits.

This provides additional evidence that the Internet offers a variety of ways to deliver medical care efficiently and improve access, while maintaining quality.

These recent study results were published in the April 2010 issue of the Archives of Dermatology, “A randomized trial to evaluate the efficacy of online follow-up visits in the management of acne“.

Acne patients who participated in “e-visits” with dermatologists experienced similar reductions in inflammatory lesions as those who had office visits. Dermatologists were satisfied with acne treatment they provided via eVisits. Although the dermatologists spent about the same amount of time per patient, the patients were spared the travel time to and from the doctor’s office.

The study explored some of the challenges of adopting a new technology into the practice workflow, and the limitations of applying eVisits across all patient populations. However, these limitations did not lessen the opportunity to derive efficiency and time savings from new technology. Because visual changes of the skin can be transmitted via the Internet and offer measurement of treatment responses, dermatology may be a medical specialty well suited for a variety of Web-based clinical applications.

How about follow up care via eVisits for rosacea (primarily a condition that affects the face and easily photographed by the patient at home)? Or how about eVisits to follow up on wound healing? There are a variety of applications.

Organizations like the Institute for Healthcare Improvement and telemedical companies are helping to move the ball forward. Of course all of this is a long way from being accepted, by both dermatologists and patients. Heck, using email to communicate with one’s doctor is still a long ways from being the norm.

But it’s interesting to think about what might lead to faster adoption. Higher gas prices that make the 15 mile drive to the doctor’s office a bit more expensive? Higher co-pays for an in-office visits? What about being told you can be seen online today, but have to wait 2 weeks to be seen in the office?

Just as the medical treatment options are evolving rapidly with the discovery of new medications and surgical procedures,  so are the ways in which medical care is delivered.

Topical Retinoids for Acne Treatment Reviewed by Lisa Benest, M.D.

Lisa Benest, M.D.Lisa Benest, M.D. , a Los Angeles dermatologist in private practice, provided her clinical opinion regarding the use of topical retinoids for the treatment of acne.

Topical retinoids are a standard component of acne treatment. They are useful for the management of both comedonal acne (blackheads and whiteheads) and inflammatory acne. In addition to generic tretinoin, there are several commonly prescribed brands of topical retinoids, including Differin™, Retin A Micro™, Tazorac™ and generic tretinoin. There are also newer brands that combine a topical retinoid with another acne medication, such as Epiduo™ (adapalene combined with benzoyl peroxide) and Ziana™ (tretinoin combined with clindamycin).

Dr. Benest wrote that “Topical retinoids (vitamin A related creams) play an integral role in the treatment and also prevention of acne. Almost all patients will benefit from a topical retinoid. The process of unblocking pores takes time and patience, often months. However, some results are seen almost immediately, they just continue to improve over time.”

Topical retinoids may be prescribed alone, particularly for cases of mild acne, or in combination with other topical or oral acne medications. They may also be prescribed for long-term use after the acne lesions have cleared to provide long-term acne control.

Dr. Benest provided her expert opinion regarding acne treatment with topical retinoids along with other leading dermatologists enrolled for the Vivacare patient education service.

Differin Acne Medication Now Available as a Lotion.

A lotion formulation of Differin, the popular prescription acne treatment, has been approved by the U.S. FDA and should be available for prescription in April 2010.

Adapalene, the active ingredient of Differin, is a topical retinoid. Topical retinoids are a category of dermatology medication derived from vitamin A. They are a fundamental component of acne therapy and have also been shown to be safe and effective for the treatment of psoriasis and aging skin.

Differin has been available as a 0.1% gel, a 0.1% cream and a 0.3% gel. The new lotion is formulated for efficacy, tolerability and spreads easily. It will be available in a convenient, easy-to-use pump dispenser.

Like other topical retinoids, Differin may be prescribed for use alone or in combination with other acne medications, particularly for cases of moderate acne or severe acne.